EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,240 JPY | -0.30% |
|
+5.74% | -11.51% |
| Apr. 24 | Biogen beats quarterly profit estimates, Alzheimer's drug sales jump | RE |
| Apr. 23 | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Presenter SpeechUnknown Executive (Executives)Thank you very much for taking your time today d...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6,259
JPY
Average target price
8,193
JPY
Spread / Average Target
+30.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.51% | 11.54B | |
| +24.72% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.19% | 233B | |
| +5.54% | 201B | |
| -10.06% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Transcript : Eisai Co., Ltd., Q3 2019 Earnings Call, Feb 04, 2019
